Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Yigal Nochomovitz's Stock Ratings
Citigroup Analyst
Yigal Nochomovitz is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
6.35%
Smart Score
Overall Average Return Percentile
49th
Number of Ratings
406
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/12/2025 | OLMA | Buy Now | Olema Pharmaceuticals | $35.37 | 69.64% | $21 → $60 | Maintains | Buy | Get Alert | |
| 12/10/2025 | DRTS | Buy Now | Alpha Tau Medical | $4.92 | 42.28% | $8 → $7 | Maintains | Buy | Get Alert | |
| 12/09/2025 | LGND | Buy Now | Ligand Pharmaceuticals | $193.41 | 39.6% | → $270 | Initiates | → Buy | Get Alert | |
| 11/17/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.35 | 71.12% | $12 → $16 | Maintains | Buy | Get Alert | |
| 11/14/2025 | CADL | Buy Now | Candel Therapeutics | $6.42 | 273.83% | $25 → $24 | Maintains | Buy | Get Alert | |
| 11/13/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.24 | 24.4% | $12 → $9 | Maintains | Neutral | Get Alert | |
| 11/12/2025 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 34.5% | $87 → $77 | Maintains | Buy | Get Alert | |
| 11/11/2025 | AVBP | Buy Now | ArriVent BioPharma | $23.86 | 29.9% | $33 → $31 | Maintains | Buy | Get Alert | |
| 11/10/2025 | BMEA | Buy Now | Biomea Fusion | $1.35 | 342.8% | $7 → $6 | Maintains | Buy | Get Alert | |
| 11/10/2025 | ONC | Buy Now | BeOne Medicines | $307.13 | 31.87% | $399 → $405 | Maintains | Buy | Get Alert | |
| 11/05/2025 | SLDB | Buy Now | Solid Biosciences | $5.76 | 143.06% | $16 → $14 | Maintains | Buy | Get Alert | |
| 11/04/2025 | KRYS | Buy Now | Krystal Biotech | $243.26 | -18.61% | $166 → $198 | Maintains | Neutral | Get Alert | |
| 11/03/2025 | ARDX | Buy Now | Ardelyx | $6.29 | 74.74% | $10 → $11 | Maintains | Buy | Get Alert | |
| 11/03/2025 | CRBU | Buy Now | Caribou Biosciences | $1.75 | 358.45% | $5 → $8 | Maintains | Buy | Get Alert | |
| 10/31/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 78.5% | $52 → $45 | Maintains | Buy | Get Alert | |
| 10/29/2025 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 166.28% | $54 → $56 | Maintains | Buy | Get Alert | |
| 10/29/2025 | NBIX | Buy Now | Neurocrine Biosciences | $152.84 | 32.81% | $175 → $203 | Maintains | Buy | Get Alert | |
| 10/28/2025 | ZBIO | Buy Now | Zenas BioPharma | $36.58 | 25.75% | $27 → $46 | Maintains | Buy | Get Alert | |
| 10/23/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.24 | 65.86% | $49 → $12 | Downgrade | Buy → Neutral | Get Alert | |
| 10/21/2025 | NBIX | Buy Now | Neurocrine Biosciences | $152.84 | 14.5% | → $175 | Initiates | → Buy | Get Alert | |
| 10/21/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $26.91 | 22.61% | → $33 | Initiates | → Buy | Get Alert | |
| 10/20/2025 | SMMT | Buy Now | Summit Therapeutics | $17.50 | 128.57% | $35 → $40 | Maintains | Buy | Get Alert | |
| 10/13/2025 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 156.77% | $47 → $54 | Maintains | Buy | Get Alert | |
| 09/29/2025 | MRUS | Buy Now | Merus | $96.74 | 0.27% | $101 → $97 | Downgrade | Buy → Neutral | Get Alert | |
| 08/12/2025 | AVBP | Buy Now | ArriVent BioPharma | $23.86 | 38.28% | $40 → $33 | Maintains | Buy | Get Alert | |
| 08/12/2025 | ARCT | Buy Now | Arcturus Therapeutics | $7.24 | 577.26% | $47 → $49 | Maintains | Buy | Get Alert | |
| 08/12/2025 | OLMA | Buy Now | Olema Pharmaceuticals | $35.37 | -40.63% | $20 → $21 | Maintains | Buy | Get Alert | |
| 08/11/2025 | ZLAB | Buy Now | Zai Lab | $17.61 | 291.82% | $66 → $69 | Maintains | Buy | Get Alert | |
| 08/11/2025 | BMEA | Buy Now | Biomea Fusion | $1.35 | 416.61% | $9 → $7 | Maintains | Buy | Get Alert | |
| 08/11/2025 | ZYME | Buy Now | Zymeworks | $25.77 | -14.63% | $19 → $22 | Maintains | Buy | Get Alert | |
| 08/07/2025 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 49.02% | $1.2 → $1.9 | Maintains | Buy | Get Alert | |
| 08/05/2025 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 149.02% | $46 → $51 | Maintains | Buy | Get Alert | |
| 08/05/2025 | KRYS | Buy Now | Krystal Biotech | $243.26 | -31.76% | $176 → $166 | Maintains | Neutral | Get Alert | |
| 08/01/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 106.27% | $46 → $52 | Maintains | Buy | Get Alert | |
| 08/01/2025 | LENZ | Buy Now | LENZ Therapeutics | $17.49 | 197.31% | $49 → $52 | Maintains | Buy | Get Alert | |
| 07/31/2025 | LENZ | Buy Now | LENZ Therapeutics | $17.49 | 180.16% | $45 → $49 | Maintains | Buy | Get Alert | |
| 07/29/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 82.47% | $41 → $46 | Maintains | Buy | Get Alert | |
| 07/24/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.32 | -67.16% | → $7 | Initiates | → Sell | Get Alert | |
| 07/16/2025 | BMEA | Buy Now | Biomea Fusion | $1.35 | 564.21% | $22 → $9 | Maintains | Buy | Get Alert | |
| 07/09/2025 | PROK | Buy Now | ProKidney | $2.21 | 307.24% | $6 → $9 | Maintains | Buy | Get Alert | |
| 06/26/2025 | SLDB | Buy Now | Solid Biosciences | $5.76 | 143.06% | → $14 | Initiates | → Buy | Get Alert | |
| 05/22/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 62.63% | $49 → $41 | Maintains | Buy | Get Alert | |
| 05/16/2025 | KRYS | Buy Now | Krystal Biotech | $243.26 | -36.28% | $215 → $155 | Maintains | Neutral | Get Alert | |
| 05/05/2025 | ARVN | Buy Now | Arvinas | $12.46 | -23.79% | $10 → $9.5 | Maintains | Neutral | Get Alert | |
| 05/02/2025 | ARDX | Buy Now | Ardelyx | $6.29 | 58.86% | $11 → $10 | Maintains | Buy | Get Alert | |
| 03/26/2025 | SMMT | Buy Now | Summit Therapeutics | $17.50 | 100% | $23 → $35 | Upgrade | Neutral → Buy | Get Alert | |
| 03/20/2025 | LENZ | Buy Now | LENZ Therapeutics | $17.49 | 168.72% | $44 → $47 | Maintains | Buy | Get Alert | |
| 03/07/2025 | ZYME | Buy Now | Zymeworks | $25.77 | -26.27% | $18 → $19 | Maintains | Buy | Get Alert | |
| 03/07/2025 | ARVN | Buy Now | Arvinas | $12.46 | 52.43% | $28 → $19 | Maintains | Neutral | Get Alert | |
| 03/06/2025 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | 31.2% | $49 → $55 | Maintains | Buy | Get Alert | |
| 03/04/2025 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 105.08% | $45 → $42 | Maintains | Buy | Get Alert | |
| 02/20/2025 | KRYS | Buy Now | Krystal Biotech | $243.26 | -11.62% | $206 → $215 | Maintains | Neutral | Get Alert | |
| 02/20/2025 | CADL | Buy Now | Candel Therapeutics | $6.42 | 289.41% | → $25 | Initiates | → Buy | Get Alert | |
| 02/18/2025 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 43.23% | $89 → $82 | Maintains | Buy | Get Alert | |
| 01/07/2025 | EYPT | Buy Now | EyePoint Pharmaceuticals | $16.27 | 102.83% | → $33 | Initiates | → Buy | Get Alert | |
| 12/09/2024 | MRUS | Buy Now | Merus | $96.74 | 0.27% | $89 → $97 | Maintains | Buy | Get Alert | |
| 11/29/2024 | APLT | Buy Now | Applied Therapeutics | $0.11 | 7384.47% | $13 → $8 | Maintains | Buy | Get Alert | |
| 11/27/2024 | APLT | Buy Now | Applied Therapeutics | $0.11 | 12062.26% | $11 → $13 | Maintains | Buy | Get Alert | |
| 11/26/2024 | CRBU | Buy Now | Caribou Biosciences | $1.75 | 243.84% | $30 → $6 | Maintains | Buy | Get Alert | |
| 11/19/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 119.73% | $37 → $45 | Maintains | Buy | Get Alert | |
| 11/12/2024 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | 16.89% | $40 → $49 | Maintains | Buy | Get Alert | |
| 11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 102.3% | $63 → $51 | Maintains | Buy | Get Alert | |
| 11/05/2024 | KRYS | Buy Now | Krystal Biotech | $243.26 | -15.32% | $204 → $206 | Maintains | Neutral | Get Alert | |
| 11/04/2024 | ARDX | Buy Now | Ardelyx | $6.29 | 58.86% | $12 → $10 | Maintains | Buy | Get Alert | |
| 11/04/2024 | ZYME | Buy Now | Zymeworks | $25.77 | -30.15% | $16 → $18 | Maintains | Buy | Get Alert | |
| 10/08/2024 | ZBIO | Buy Now | Zenas BioPharma | $36.58 | -26.19% | → $27 | Initiates | → Buy | Get Alert | |
| 10/02/2024 | STTK | Buy Now | Shattuck Labs | $2.92 | -31.39% | $8 → $2 | Downgrade | Buy → Neutral | Get Alert | |
| 09/27/2024 | SMMT | Buy Now | Summit Therapeutics | $17.50 | 31.43% | $19 → $23 | Downgrade | Buy → Neutral | Get Alert | |
| 09/19/2024 | APLT | Buy Now | Applied Therapeutics | $0.11 | 10191.15% | $8 → $11 | Maintains | Buy | Get Alert | |
| 09/11/2024 | AVBP | Buy Now | ArriVent BioPharma | $23.86 | 50.85% | $30 → $36 | Maintains | Buy | Get Alert | |
| 09/09/2024 | SMMT | Buy Now | Summit Therapeutics | $17.50 | 8.57% | $13 → $19 | Maintains | Buy | Get Alert | |
| 08/27/2024 | IDYA | Buy Now | IDEAYA Biosciences | $33.88 | 71.17% | $60 → $58 | Maintains | Buy | Get Alert | |
| 08/27/2024 | BMEA | Buy Now | Biomea Fusion | $1.35 | 1523.62% | $45 → $22 | Maintains | Buy | Get Alert | |
| 08/27/2024 | APLT | Buy Now | Applied Therapeutics | $0.11 | 7384.47% | $7 → $8 | Maintains | Buy | Get Alert | |
| 08/16/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 66.02% | $30 → $34 | Maintains | Buy | Get Alert | |
| 08/15/2024 | MGNX | Buy Now | Macrogenics | $1.40 | 900% | $16 → $14 | Maintains | Buy | Get Alert | |
| 08/15/2024 | STTK | Buy Now | Shattuck Labs | $2.92 | 174.44% | $9 → $8 | Maintains | Buy | Get Alert | |
| 08/08/2024 | BGNE | Buy Now | BeiGene | — | — | $269 → $288 | Maintains | Buy | Get Alert | |
| 08/06/2024 | KRYS | Buy Now | Krystal Biotech | $243.26 | -16.14% | $195 → $204 | Downgrade | Buy → Neutral | Get Alert | |
| 08/02/2024 | ARDX | Buy Now | Ardelyx | $6.29 | 90.63% | $10 → $12 | Maintains | Buy | Get Alert | |
| 07/03/2024 | ARDX | Buy Now | Ardelyx | $6.29 | 58.86% | $14 → $10 | Maintains | Buy | Get Alert | |
| 06/26/2024 | MRUS | Buy Now | Merus | $96.74 | -3.87% | $70 → $93 | Maintains | Buy | Get Alert | |
| 06/18/2024 | OVID | Buy Now | Ovid Therapeutics | $1.57 | -23.57% | $3.5 → $1.2 | Maintains | Neutral | Get Alert | |
| 06/17/2024 | STTK | Buy Now | Shattuck Labs | $2.92 | 208.75% | $10 → $9 | Maintains | Buy | Get Alert | |
| 06/07/2024 | BMEA | Buy Now | Biomea Fusion | $1.35 | 3221.03% | $90 → $45 | Maintains | Buy | Get Alert | |
| 06/03/2024 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 80.69% | $36 → $38 | Maintains | Buy | Get Alert | |
| 05/31/2024 | SMMT | Buy Now | Summit Therapeutics | $17.50 | -25.71% | $7 → $13 | Maintains | Buy | Get Alert | |
| 05/31/2024 | CALT | Buy Now | Calliditas Therapeutics | — | — | → $39 | Downgrade | Buy → Neutral | Get Alert | |
| 05/23/2024 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 46.72% | $89 → $84 | Maintains | Buy | Get Alert | |
| 05/09/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 46.48% | $32 → $30 | Maintains | Buy | Get Alert | |
| 05/08/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 138% | $67 → $60 | Maintains | Buy | Get Alert | |
| 05/07/2024 | OVID | Buy Now | Ovid Therapeutics | $1.57 | 122.93% | $4 → $3.5 | Maintains | Neutral | Get Alert | |
| 05/07/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.35 | 49.73% | $15 → $14 | Maintains | Buy | Get Alert | |
| 05/07/2024 | SMMT | Buy Now | Summit Therapeutics | $17.50 | -60% | → $7 | Initiates | → Buy | Get Alert | |
| 05/03/2024 | ZYME | Buy Now | Zymeworks | $25.77 | -37.91% | $17 → $16 | Maintains | Buy | Get Alert | |
| 05/03/2024 | ARDX | Buy Now | Ardelyx | $6.29 | 122.4% | $13 → $14 | Maintains | Buy | Get Alert | |
| 04/18/2024 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 55.46% | $88 → $89 | Maintains | Buy | Get Alert | |
| 04/18/2024 | PRQR | Buy Now | ProQR Therapeutics | $2.33 | -14.16% | $1.8 → $2 | Maintains | Neutral | Get Alert | |
| 04/10/2024 | LENZ | Buy Now | LENZ Therapeutics | $17.49 | 94.4% | → $34 | Initiates | → Buy | Get Alert | |
| 03/21/2024 | IDYA | Buy Now | IDEAYA Biosciences | $33.88 | 77.07% | $40 → $60 | Maintains | Buy | Get Alert | |
| 03/11/2024 | MGNX | Buy Now | Macrogenics | $1.40 | 1685.71% | $13 → $25 | Maintains | Buy | Get Alert | |
| 03/07/2024 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | -90.46% | $3 → $4 | Maintains | Buy | Get Alert | |
| 02/29/2024 | ZLAB | Buy Now | Zai Lab | $17.61 | 274.79% | $123 → $66 | Maintains | Buy | Get Alert | |
| 02/27/2024 | KRYS | Buy Now | Krystal Biotech | $243.26 | -19.84% | $160 → $195 | Maintains | Buy | Get Alert | |
| 02/26/2024 | HARP | Buy Now | Harpoon Therapeutics | — | — | $13 → $23 | Downgrade | Buy → Neutral | Get Alert | |
| 02/20/2024 | AVBP | Buy Now | ArriVent BioPharma | $23.86 | 25.71% | → $30 | Initiates | → Buy | Get Alert | |
| 02/16/2024 | APLT | Buy Now | Applied Therapeutics | $0.11 | 6448.91% | $5 → $7 | Maintains | Buy | Get Alert | |
| 02/15/2024 | ARVN | Buy Now | Arvinas | $12.46 | 341.24% | $36 → $55 | Downgrade | Buy → Neutral | Get Alert | |
| 02/14/2024 | ARVN | Buy Now | Arvinas | $12.46 | 341.24% | $36 → $55 | Downgrade | Buy → Neutral | Get Alert | |
| 02/08/2024 | ARCT | Buy Now | Arcturus Therapeutics | $7.24 | 563.44% | $40 → $48 | Maintains | Buy | Get Alert | |
| 01/30/2024 | OLMA | Buy Now | Olema Pharmaceuticals | $35.37 | -43.45% | → $20 | Initiates | → Buy | Get Alert | |
| 01/10/2024 | ARDX | Buy Now | Ardelyx | $6.29 | 122.4% | $9 → $14 | Maintains | Buy | Get Alert | |
| 12/20/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $48 → $59 | Downgrade | Buy → Neutral | Get Alert | |
| 12/20/2023 | MGNX | Buy Now | Macrogenics | $1.40 | 828.57% | $7 → $13 | Upgrade | Neutral → Buy | Get Alert | |
| 12/15/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 165.77% | $70 → $67 | Maintains | Buy | Get Alert | |
| 12/08/2023 | BMEA | Buy Now | Biomea Fusion | $1.35 | 6542.07% | → $90 | Reiterates | Buy → Buy | Get Alert | |
| 10/26/2023 | ZLAB | Buy Now | Zai Lab | $17.61 | 626.86% | $130 → $128 | Maintains | Buy | Get Alert | |
| 10/26/2023 | BGNE | Buy Now | BeiGene | — | — | $290 → $285 | Maintains | Buy | Get Alert | |
| 10/24/2023 | ARVN | Buy Now | Arvinas | $12.46 | 188.81% | $72 → $36 | Maintains | Buy | Get Alert | |
| 10/24/2023 | HARP | Buy Now | Harpoon Therapeutics | — | — | $33 → $13 | Maintains | Buy | Get Alert | |
| 10/17/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 72.92% | $25 → $8 | Maintains | Buy | Get Alert | |
| 10/06/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 177.67% | $54 → $70 | Maintains | Buy | Get Alert | |
| 09/21/2023 | BGNE | Buy Now | BeiGene | — | — | $285 → $290 | Maintains | Buy | Get Alert | |
| 09/18/2023 | PRQR | Buy Now | ProQR Therapeutics | $2.33 | -22.75% | $2.1 → $1.8 | Maintains | Neutral | Get Alert | |
| 09/18/2023 | RAIN | Buy Now | Rain Oncology | $6.35 | -84.24% | $1.5 → $1 | Maintains | Neutral | Get Alert | |
| 09/18/2023 | HARP | Buy Now | Harpoon Therapeutics | — | — | $60 → $33 | Maintains | Buy | Get Alert | |
| 08/30/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 114.2% | $45 → $54 | Maintains | Buy | Get Alert | |
| 08/29/2023 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | $4 → $3 | Maintains | Buy | Get Alert | |
| 08/29/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | $12 → $11 | Maintains | Buy | Get Alert | |
| 08/29/2023 | GRTX | Buy Now | Galera Therapeutics | $0.03 | 796.06% | $0.4 → $0.25 | Maintains | Neutral | Get Alert | |
| 08/24/2023 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 109.22% | $41 → $44 | Maintains | Buy | Get Alert | |
| 08/21/2023 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | -92.21% | $2 → $1.4 | Maintains | Sell | Get Alert | |
| 08/21/2023 | ARVN | Buy Now | Arvinas | $12.46 | 477.62% | $77 → $72 | Maintains | Buy | Get Alert | |
| 08/18/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 22.27% | → $70 | Upgrade | Neutral → Buy | Get Alert | |
| 08/17/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 22.27% | → $70 | Upgrade | Neutral → Buy | Get Alert | |
| 08/10/2023 | MRUS | Buy Now | Merus | $96.74 | -52.45% | $48 → $46 | Maintains | Buy | Get Alert | |
| 08/10/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $51 → $48 | Upgrade | Neutral → Buy | Get Alert | |
| 08/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $127 → $172.5 | Downgrade | Buy → Neutral | Get Alert | |
| 07/26/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 70.9% | $31 → $35 | Maintains | Buy | Get Alert | |
| 07/21/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 217.33% | $106 → $80 | Maintains | Buy | Get Alert | |
| 07/20/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 217.33% | $106 → $80 | Maintains | Buy | Get Alert | |
| 07/17/2023 | BGNE | Buy Now | BeiGene | — | — | → $275 | Initiates | → Buy | Get Alert | |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $1.35 | 6542.07% | $53 → $90 | Maintains | Buy | Get Alert | |
| 06/07/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 269.34% | $130 → $133 | Maintains | Buy | Get Alert | |
| 06/01/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 440.37% | $28 → $25 | Maintains | Buy | Get Alert | |
| 05/31/2023 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 527.45% | $6 → $8 | Maintains | Buy | Get Alert | |
| 05/26/2023 | PRQR | Buy Now | ProQR Therapeutics | $2.33 | -9.87% | $2.25 → $2.1 | Maintains | Neutral | Get Alert | |
| 05/26/2023 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 94.96% | $40 → $41 | Maintains | Buy | Get Alert | |
| 05/26/2023 | UBX | Buy Now | Unity Biotechnology | — | — | $5 → $6 | Maintains | Buy | Get Alert | |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | $6.35 | -76.36% | $24 → $1.5 | Downgrade | Buy → Neutral | Get Alert | |
| 05/23/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 22.27% | $55 → $70 | Maintains | Neutral | Get Alert | |
| 05/18/2023 | BMEA | Buy Now | Biomea Fusion | $1.35 | 3811.44% | $55 → $53 | Maintains | Buy | Get Alert | |
| 05/18/2023 | MRUS | Buy Now | Merus | $96.74 | -50.38% | $47 → $48 | Maintains | Buy | Get Alert | |
| 05/18/2023 | ZYME | Buy Now | Zymeworks | $25.77 | -30.15% | $17 → $18 | Maintains | Buy | Get Alert | |
| 05/11/2023 | ZLAB | Buy Now | Zai Lab | $17.61 | 638.22% | $138 → $130 | Maintains | Buy | Get Alert | |
| 05/11/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $53 → $51 | Maintains | Neutral | Get Alert | |
| 05/10/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 51.37% | $32 → $31 | Maintains | Buy | Get Alert | |
| 05/08/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 320.47% | $88 → $106 | Maintains | Buy | Get Alert | |
| 05/05/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 261.01% | $130 → $130 | Maintains | Buy | Get Alert | |
| 04/17/2023 | MRUS | Buy Now | Merus | $96.74 | -51.42% | $38 → $47 | Maintains | Buy | Get Alert | |
| 04/07/2023 | BMEA | Buy Now | Biomea Fusion | $1.35 | 3959.04% | $60 → $55 | Maintains | Buy | Get Alert | |
| 04/05/2023 | MRUS | Buy Now | Merus | $96.74 | -60.72% | $30 → $38 | Maintains | Buy | Get Alert | |
| 04/05/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.35 | -14.44% | $9 → $8 | Maintains | Buy | Get Alert | |
| 04/05/2023 | APLT | Buy Now | Applied Therapeutics | $0.11 | 4577.79% | $23 → $5 | Maintains | Buy | Get Alert | |
| 04/05/2023 | CLLS | Buy Now | Cellectis | $4.73 | 238.27% | $24 → $16 | Maintains | Buy | Get Alert | |
| 03/29/2023 | BMEA | Buy Now | Biomea Fusion | $1.35 | 4328.04% | $20 → $60 | Maintains | Buy | Get Alert | |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | — | — | $15 → $5 | Maintains | Buy | Get Alert | |
| 03/18/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 261.01% | $135 → $130 | Maintains | Buy | Get Alert | |
| 03/18/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -3.93% | $63 → $55 | Maintains | Neutral | Get Alert | |
| 03/10/2023 | ZYME | Buy Now | Zymeworks | $25.77 | -34.03% | $21 → $17 | Maintains | Buy | Get Alert | |
| 03/10/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 505.21% | $23 → $28 | Maintains | Buy | Get Alert | |
| 03/09/2023 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | -92.84% | $2 → $3 | Maintains | Buy | Get Alert | |
| 03/08/2023 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 90.2% | $42 → $40 | Maintains | Buy | Get Alert | |
| 03/02/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 56.25% | $29 → $32 | Maintains | Buy | Get Alert | |
| 03/02/2023 | FATE | Buy Now | Fate Therapeutics | $1.12 | 792.86% | $9 → $10 | Maintains | Buy | Get Alert | |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $53 → $120 | Maintains | Buy | Get Alert | |
| 02/24/2023 | BMEA | Buy Now | Biomea Fusion | $1.35 | 1376.01% | → $20 | Initiates | → Buy | Get Alert | |
| 02/24/2023 | CALT | Buy Now | Calliditas Therapeutics | — | — | $76 → $79 | Maintains | Buy | Get Alert | |
| 02/21/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 260.97% | $86 → $91 | Maintains | Buy | Get Alert | |
| 01/09/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 274.9% | $138 → $135 | Maintains | Buy | Get Alert | |
| 12/30/2022 | ARDX | Buy Now | Ardelyx | $6.29 | 11.2% | $6 → $7 | Maintains | Buy | Get Alert | |
| 12/20/2022 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 99.71% | $37 → $42 | Maintains | Buy | Get Alert | |
| 12/09/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $121 → $53 | Downgrade | Buy → Neutral | Get Alert | |
| 12/05/2022 | ARVN | Buy Now | Arvinas | $12.46 | 477.62% | $88 → $72 | Maintains | Buy | Get Alert | |
| 12/02/2022 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 11/23/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 10.04% | $83 → $63 | Maintains | Neutral | Get Alert | |
| 11/23/2022 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 75.94% | $40 → $37 | Maintains | Buy | Get Alert | |
| 11/23/2022 | RAIN | Buy Now | Rain Oncology | $6.35 | 357.04% | $30 → $29 | Maintains | Buy | Get Alert | |
| 11/23/2022 | MGNX | Buy Now | Macrogenics | $1.40 | 400% | $16 → $7 | Downgrade | Buy → Neutral | Get Alert | |
| 11/22/2022 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 370.59% | $16 → $6 | Maintains | Buy | Get Alert | |
| 11/21/2022 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 397.14% | $26 → $23 | Maintains | Buy | Get Alert | |
| 11/16/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $127 → $121 | Maintains | Buy | Get Alert | |
| 11/16/2022 | MRUS | Buy Now | Merus | $96.74 | -68.99% | $34 → $30 | Maintains | Buy | Get Alert | |
| 11/16/2022 | FATE | Buy Now | Fate Therapeutics | $1.12 | 7042.86% | $87 → $80 | Maintains | Buy | Get Alert | |
| 11/11/2022 | ZLAB | Buy Now | Zai Lab | $17.61 | 621.18% | $199 → $127 | Maintains | Buy | Get Alert | |
| 11/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $51 → $53 | Maintains | Buy | Get Alert | |
| 11/03/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 283.23% | $142 → $138 | Maintains | Buy | Get Alert | |
| 11/03/2022 | ARCT | Buy Now | Arcturus Therapeutics | $7.24 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 10/27/2022 | IDYA | Buy Now | IDEAYA Biosciences | $33.88 | -23.27% | → $26 | Initiates | → Buy | Get Alert | |
| 10/14/2022 | PROK | Buy Now | ProKidney | $2.21 | 623.98% | → $16 | Initiates | → Buy | Get Alert | |
| 09/22/2022 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $12 | Initiates | → Buy | Get Alert | |
| 09/16/2022 | OPT | Buy Now | Opthea | — | — | $45 → $44 | Maintains | Buy | Get Alert | |
| 09/16/2022 | IPHA | Buy Now | Innate Pharma | $1.84 | 552.17% | $16 → $12 | Maintains | Buy | Get Alert | |
| 09/14/2022 | ZYME | Buy Now | Zymeworks | $25.77 | -18.51% | $27 → $21 | Maintains | Buy | Get Alert | |
| 08/29/2022 | OVID | Buy Now | Ovid Therapeutics | $1.57 | 59.24% | $2.4 → $2.5 | Maintains | Neutral | Get Alert | |
| 08/29/2022 | MGNX | Buy Now | Macrogenics | $1.40 | 1042.86% | $13 → $16 | Maintains | Buy | Get Alert | |
| 08/29/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $7 → $6 | Maintains | Buy | Get Alert | |
| 08/29/2022 | CRBU | Buy Now | Caribou Biosciences | $1.75 | 2077.65% | $39 → $38 | Maintains | Buy | Get Alert | |
| 08/29/2022 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 08/26/2022 | ZYME | Buy Now | Zymeworks | $25.77 | 4.77% | $28 → $27 | Maintains | Buy | Get Alert | |
| 08/18/2022 | RCUS | Buy Now | Arcus Biosciences | $21.03 | 90.2% | $48 → $40 | Maintains | Buy | Get Alert | |
| 08/17/2022 | MRUS | Buy Now | Merus | $96.74 | -64.85% | $37 → $34 | Maintains | Buy | Get Alert | |
| 08/17/2022 | APLT | Buy Now | Applied Therapeutics | $0.11 | 21417.85% | $29 → $23 | Maintains | Buy | Get Alert | |
| 08/15/2022 | UBX | Buy Now | Unity Biotechnology | — | — | $5 → $8 | Maintains | Buy | Get Alert | |
| 08/09/2022 | ZLAB | Buy Now | Zai Lab | $17.61 | 1030.04% | $193 → $199 | Maintains | Buy | Get Alert | |
| 08/02/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 294.33% | $146 → $142 | Maintains | Buy | Get Alert | |
| 08/02/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 44.98% | $53 → $83 | Maintains | Neutral | Get Alert | |
| 07/20/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 241.13% | $81 → $86 | Maintains | Buy | Get Alert | |
| 07/20/2022 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | -83.31% | → $3 | Downgrade | Neutral → Sell | Get Alert | |
| 07/07/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $208 → $127 | Maintains | Buy | Get Alert | |
| 07/01/2022 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 1468.63% | $18 → $20 | Maintains | Buy | Get Alert | |
| 06/09/2022 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | -98.09% | $7 → $0.8 | Downgrade | Buy → Neutral | Get Alert | |
| 06/09/2022 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 461.98% | $21 → $26 | Maintains | Buy | Get Alert | |
| 06/01/2022 | STTK | Buy Now | Shattuck Labs | $2.92 | 345.97% | → $13 | Initiates | → Buy | Get Alert | |
| 05/27/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $43 → $46 | Maintains | Buy | Get Alert | |
| 05/20/2022 | OVID | Buy Now | Ovid Therapeutics | $1.57 | 52.87% | $4 → $2.4 | Maintains | Neutral | Get Alert | |
| 05/20/2022 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.35 | -3.74% | $10 → $9 | Maintains | Buy | Get Alert | |
| 05/20/2022 | ARVN | Buy Now | Arvinas | $12.46 | 726.31% | $113 → $103 | Maintains | Buy | Get Alert | |
| 05/20/2022 | APLT | Buy Now | Applied Therapeutics | $0.11 | 27031.2% | $30 → $29 | Maintains | Buy | Get Alert | |
| 05/19/2022 | MRUS | Buy Now | Merus | $96.74 | -61.75% | $38 → $37 | Maintains | Buy | Get Alert | |
| 05/17/2022 | UBX | Buy Now | Unity Biotechnology | — | — | $6 → $5 | Maintains | Buy | Get Alert | |
| 05/17/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -7.42% | $64 → $53 | Maintains | Neutral | Get Alert | |
| 05/13/2022 | CRBU | Buy Now | Caribou Biosciences | $1.75 | 2134.96% | $29 → $39 | Maintains | Buy | Get Alert | |
| 05/12/2022 | ZLAB | Buy Now | Zai Lab | $17.61 | 995.97% | $198 → $193 | Maintains | Buy | Get Alert | |
| 05/10/2022 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | -55.51% | $23 → $8 | Downgrade | Buy → Neutral | Get Alert | |
| 05/10/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 305.44% | $150 → $146 | Maintains | Buy | Get Alert | |
| 05/09/2022 | ZYME | Buy Now | Zymeworks | $25.77 | 8.65% | $30 → $28 | Maintains | Buy | Get Alert | |
| 05/09/2022 | ZYME | Buy Now | Zymeworks | $25.77 | 8.65% | $30 → $28 | Maintains | Buy | Get Alert | |
| 05/05/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $227 → $208 | Maintains | Buy | Get Alert | |
| 03/16/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | $14 → $7 | Maintains | Buy | Get Alert | |
| 03/15/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 11.79% | $90 → $64 | Maintains | Neutral | Get Alert | |
| 03/15/2022 | ARCT | Buy Now | Arcturus Therapeutics | $7.24 | 1088.67% | $114 → $86 | Maintains | Buy | Get Alert | |
| 03/02/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $244 → $227 | Maintains | Buy | Get Alert | |
| 02/28/2022 | ZYME | Buy Now | Zymeworks | $25.77 | 16.41% | $53 → $30 | Maintains | Buy | Get Alert | |
| 02/28/2022 | MGNX | Buy Now | Macrogenics | $1.40 | 1400% | $23 → $21 | Upgrade | Neutral → Buy | Get Alert | |
| 12/21/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 353.91% | $25 → $21 | Maintains | Buy | Get Alert | |
| 12/20/2021 | GRTX | Buy Now | Galera Therapeutics | $0.03 | 71584.59% | $11 → $20 | Maintains | Buy | Get Alert | |
| 12/03/2021 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 57.2% | $132 → $90 | Maintains | Neutral | Get Alert | |
| 12/01/2021 | ARDX | Buy Now | Ardelyx | $6.29 | 106.51% | $7 → $13 | Maintains | Buy | Get Alert | |
| 11/24/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 185.6% | $65 → $72 | Maintains | Buy | Get Alert | |
| 11/15/2021 | CRBU | Buy Now | Caribou Biosciences | $1.75 | 1447.28% | → $27 | Upgrade | Neutral → Buy | Get Alert | |
| 11/11/2021 | ZLAB | Buy Now | Zai Lab | $17.61 | 1132.25% | $222 → $217 | Maintains | Buy | Get Alert | |
| 11/09/2021 | FATE | Buy Now | Fate Therapeutics | $1.12 | 7667.86% | $94 → $87 | Upgrade | Neutral → Buy | Get Alert | |
| 09/28/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | → $16 | Upgrade | Neutral → Buy | Get Alert | |
| 09/28/2021 | PBYI | Buy Now | Puma Biotechnology | $5.89 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 08/25/2021 | OVID | Buy Now | Ovid Therapeutics | $1.57 | 154.78% | $4.5 → $4 | Maintains | Neutral | Get Alert | |
| 08/25/2021 | ARCT | Buy Now | Arcturus Therapeutics | $7.24 | 1475.67% | $118 → $114 | Maintains | Buy | Get Alert | |
| 08/17/2021 | CRBU | Buy Now | Caribou Biosciences | $1.75 | 1447.28% | → $27 | Initiates | → Neutral | Get Alert | |
| 08/09/2021 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | $26 → $27 | Maintains | Buy | Get Alert | |
| 08/09/2021 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | → $32 | Downgrade | Buy → Neutral | Get Alert | |
| 07/23/2021 | ARVN | Buy Now | Arvinas | $12.46 | 1127.44% | $118 → $153 | Maintains | Buy | Get Alert | |
| 07/06/2021 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.35 | 263.64% | → $34 | Upgrade | Neutral → Buy | Get Alert | |
| 06/28/2021 | UBX | Buy Now | Unity Biotechnology | — | — | — | Upgrade | Sell → Buy | Get Alert | |
| 06/14/2021 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | 130.57% | $55 → $132 | Upgrade | Sell → Neutral | Get Alert | |
| 06/08/2021 | HARP | Buy Now | Harpoon Therapeutics | — | — | $25 → $16 | Downgrade | Buy → Neutral | Get Alert | |
| 06/07/2021 | MRUS | Buy Now | Merus | $96.74 | -67.96% | $24 → $31 | Upgrade | Neutral → Buy | Get Alert | |
| 06/04/2021 | MRTX | Buy Now | Mirati Therapeutics | — | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 05/25/2021 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.48 | 17.19% | → $24 | Initiates | → Buy | Get Alert | |
| 05/21/2021 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -3.93% | $45 → $55 | Maintains | Sell | Get Alert | |
| 05/20/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $234 → $244 | Maintains | Buy | Get Alert | |
| 05/18/2021 | RAIN | Buy Now | Rain Oncology | $6.35 | 341.28% | → $28 | Initiates | → Buy | Get Alert | |
| 05/06/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 319.33% | $160 → $151 | Upgrade | Neutral → Buy | Get Alert | |
| 04/28/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 440.37% | $22 → $25 | Maintains | Buy | Get Alert | |
| 03/12/2021 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 375.52% | $22 → $22 | Maintains | Buy | Get Alert | |
| 03/01/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | $137 → $171 | Maintains | Buy | Get Alert | |
| 01/25/2021 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.35 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 01/25/2021 | ZYME | Buy Now | Zymeworks | $25.77 | 105.67% | $50 → $53 | Downgrade | Buy → Neutral | Get Alert | |
| 12/08/2020 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 370.59% | $2.1 → $6 | Upgrade | Neutral → Buy | Get Alert | |
| 12/07/2020 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -21.4% | → $45 | Maintains | Sell | Get Alert | |
| 12/02/2020 | OVID | Buy Now | Ovid Therapeutics | $1.57 | 154.78% | $10 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 11/23/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 165.77% | $53 → $67 | Maintains | Buy | Get Alert | |
| 11/17/2020 | OPT | Buy Now | Opthea | — | — | → $48 | Initiates | → Buy | Get Alert | |
| 10/06/2020 | ARCT | Buy Now | Arcturus Therapeutics | $7.24 | 798.41% | → $65 | Initiates | → Buy | Get Alert | |
| 09/18/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | $127 → $183 | Downgrade | Buy → Neutral | Get Alert | |
| 08/26/2020 | OVID | Buy Now | Ovid Therapeutics | $1.57 | 536.94% | $9 → $10 | Maintains | Buy | Get Alert | |
| 08/19/2020 | CLLS | Buy Now | Cellectis | $4.73 | 576.53% | $15 → $32 | Upgrade | Neutral → Buy | Get Alert | |
| 08/18/2020 | UBX | Buy Now | Unity Biotechnology | — | — | $31 → $5 | Downgrade | Buy → Neutral | Get Alert | |
| 08/11/2020 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $254 → $244 | Maintains | Buy | Get Alert | |
| 08/11/2020 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 375.52% | $24 → $22 | Maintains | Buy | Get Alert | |
| 08/10/2020 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 103.74% | $14 → $12 | Maintains | Neutral | Get Alert | |
| 08/10/2020 | HARP | Buy Now | Harpoon Therapeutics | — | — | $24 → $25 | Maintains | Buy | Get Alert | |
| 08/06/2020 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | -80.92% | $7 → $8 | Maintains | Buy | Get Alert | |
| 08/05/2020 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -45.85% | $31 → $31 | Maintains | Sell | Get Alert | |
| 08/03/2020 | MGNX | Buy Now | Macrogenics | $1.40 | 1757.14% | $25 → $26 | Downgrade | Buy → Neutral | Get Alert | |
| 06/30/2020 | HARP | Buy Now | Harpoon Therapeutics | — | — | $23 → $24 | Maintains | Buy | Get Alert | |
| 06/30/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 114.2% | $56 → $54 | Maintains | Buy | Get Alert | |
| 06/02/2020 | ZYME | Buy Now | Zymeworks | $25.77 | 94.02% | $49 → $50 | Maintains | Buy | Get Alert | |
| 06/02/2020 | XLRN | Buy Now | Acceleron Pharma | — | — | $136 → $137 | Maintains | Buy | Get Alert | |
| 05/19/2020 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.35 | 274.33% | → $35 | Initiates | → Neutral | Get Alert | |
| 05/08/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 83.28% | $53 → $66 | Maintains | Neutral | Get Alert | |
| 04/28/2020 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 64.71% | $2.3 → $2.1 | Maintains | Neutral | Get Alert | |
| 04/23/2020 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 03/31/2020 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $328 → $254 | Maintains | Buy | Get Alert | |
| 03/04/2020 | FATE | Buy Now | Fate Therapeutics | $1.12 | 3560.71% | $26 → $41 | Maintains | Buy | Get Alert | |
| 03/04/2020 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -45.85% | $28 → $31 | Maintains | Sell | Get Alert | |
| 03/02/2020 | XLRN | Buy Now | Acceleron Pharma | — | — | $138 → $136 | Maintains | Buy | Get Alert | |
| 02/12/2020 | ARDX | Buy Now | Ardelyx | $6.29 | 106.51% | → $13 | Initiates | → Buy | Get Alert | |
| 01/09/2020 | APLT | Buy Now | Applied Therapeutics | $0.11 | 41064.58% | $29 → $44 | Maintains | Buy | Get Alert | |
| 12/30/2019 | ZLAB | Buy Now | Zai Lab | $17.61 | 377% | $65 → $84 | Maintains | Buy | Get Alert | |
| 12/18/2019 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | $25 → $39 | Maintains | Buy | Get Alert | |
| 12/02/2019 | GRTX | Buy Now | Galera Therapeutics | $0.03 | 71584.59% | → $20 | Initiates | → Buy | Get Alert | |
| 11/12/2019 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $241 → $328 | Maintains | Buy | Get Alert | |
| 11/08/2019 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 213.73% | $3 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 11/07/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 24.97% | $66 → $45 | Maintains | Neutral | Get Alert | |
| 11/07/2019 | MGNX | Buy Now | Macrogenics | $1.40 | 1185.71% | $39 → $18 | Maintains | Buy | Get Alert | |
| 10/15/2019 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $194 → $241 | Maintains | Buy | Get Alert | |
| 09/24/2019 | OVID | Buy Now | Ovid Therapeutics | $1.57 | 536.94% | $8 → $10 | Maintains | Buy | Get Alert | |
| 09/24/2019 | OVID | Buy Now | Ovid Therapeutics | $1.57 | 536.94% | $8 → $10 | Maintains | Buy | Get Alert | |
| 08/27/2019 | ZYME | Buy Now | Zymeworks | $25.77 | 90.14% | $22 → $49 | Maintains | Buy | Get Alert | |
| 07/30/2019 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 135.29% | $15 → $3 | Maintains | Buy | Get Alert | |
| 06/26/2019 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | → $22 | Initiates | → Buy | Get Alert | |
| 06/10/2019 | APLT | Buy Now | Applied Therapeutics | $0.11 | 27031.2% | → $29 | Initiates | → Buy | Get Alert | |
| 06/05/2019 | ARVN | Buy Now | Arvinas | $12.46 | 76.49% | $21 → $22 | Downgrade | Buy → Neutral | Get Alert | |
| 06/04/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | $76 → $132 | Upgrade | Neutral → Buy | Get Alert | |
| 06/04/2019 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | — | — | Upgrade | Sell → Neutral | Get Alert | |
| 05/31/2019 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $185 → $190 | Maintains | Buy | Get Alert | |
| 05/24/2019 | HARP | Buy Now | Harpoon Therapeutics | — | — | — | Assumes | → Buy | Get Alert | |
| 05/24/2019 | CLLS | Buy Now | Cellectis | $4.73 | — | — | Assumes | → Neutral | Get Alert | |
| 05/24/2019 | FATE | Buy Now | Fate Therapeutics | $1.12 | 2221.43% | $20 → $26 | Assumes | → Buy | Get Alert | |
| 05/10/2019 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 307.47% | → $24 | Downgrade | Buy → Neutral | Get Alert | |
| 03/21/2019 | MRUS | Buy Now | Merus | $96.74 | -83.46% | $18 → $16 | Maintains | Neutral | Get Alert | |
| 03/15/2019 | MRUS | Buy Now | Merus | $96.74 | -83.46% | $18 → $16 | Maintains | Neutral | Get Alert | |
| 03/01/2019 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 1088.46% | $67 → $70 | Maintains | Buy | Get Alert | |
| 02/21/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 72.17% | $54 → $62 | Maintains | Neutral | Get Alert | |
| 02/07/2019 | MGNX | Buy Now | Macrogenics | $1.40 | 2685.71% | $10 → $39 | Upgrade | Sell → Buy | Get Alert | |
| 02/04/2019 | MGNX | Buy Now | Macrogenics | $1.40 | 614.29% | $22 → $10 | Downgrade | Neutral → Sell | Get Alert | |
| 01/22/2019 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -63.32% | $28 → $21 | Downgrade | Neutral → Sell | Get Alert | |
| 12/04/2018 | ALDX | Buy Now | Aldeyra Therapeutics | $4.63 | 397.14% | → $23 | Initiates | → Buy | Get Alert | |
| 11/16/2018 | LOXO | Buy Now | Loxo Oncology | — | — | $233 → $213 | Maintains | Buy | Get Alert | |
| 11/08/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 49.96% | $46 → $54 | Upgrade | Sell → Neutral | Get Alert | |
| 11/02/2018 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 1939.22% | $27 → $26 | Maintains | Buy | Get Alert | |
| 10/29/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 27.74% | $49 → $46 | Maintains | Sell | Get Alert | |
| 10/24/2018 | LOXO | Buy Now | Loxo Oncology | — | — | $235 → $233 | Maintains | Buy | Get Alert | |
| 09/18/2018 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 2463.67% | $164 → $151 | Maintains | Buy | Get Alert | |
| 08/27/2018 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | -79.72% | → $8.5 | Initiates | → Buy | Get Alert | |
| 08/24/2018 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -12.66% | $51 → $50 | Maintains | Neutral | Get Alert | |
| 08/09/2018 | KERX | Buy Now | Keryx Biopharmaceuticals | — | — | $4.75 → $4 | Maintains | Neutral | Get Alert | |
| 08/09/2018 | ARDX | Buy Now | Ardelyx | $6.29 | 74.74% | $17 → $11 | Maintains | Buy | Get Alert | |
| 08/02/2018 | ZYME | Buy Now | Zymeworks | $25.77 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 08/01/2018 | FATE | Buy Now | Fate Therapeutics | $1.12 | 1685.71% | → $20 | Initiates | → Buy | Get Alert | |
| 07/25/2018 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $95 → $185 | Maintains | Buy | Get Alert | |
| 07/24/2018 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $76 → $95 | Maintains | Buy | Get Alert | |
| 06/28/2018 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 2684.38% | $146 → $164 | Maintains | Buy | Get Alert | |
| 06/21/2018 | ZYME | Buy Now | Zymeworks | $25.77 | -26.27% | $20 → $19 | Maintains | Neutral | Get Alert | |
| 06/11/2018 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | 27.92% | $25 → $23 | Maintains | Sell | Get Alert | |
| 05/29/2018 | UBX | Buy Now | Unity Biotechnology | — | — | → $32 | Initiates | → Buy | Get Alert | |
| 05/04/2018 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 2017.65% | $28 → $27 | Maintains | Buy | Get Alert | |
| 03/05/2018 | MRTX | Buy Now | Mirati Therapeutics | — | — | $23 → $37 | Maintains | Buy | Get Alert | |
| 03/05/2018 | LOXO | Buy Now | Loxo Oncology | — | — | $108 → $151 | Maintains | Buy | Get Alert | |
| 02/28/2018 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -10.92% | $20 → $51 | Maintains | Neutral | Get Alert | |
| 02/15/2018 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | — | — | Downgrade | Neutral → Sell | Get Alert | |
| 01/24/2018 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 2378.78% | $164 → $146 | Maintains | Buy | Get Alert | |
| 01/03/2018 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | — | — | Upgrade | Sell → Neutral | Get Alert | |
| 12/04/2017 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | -8.77% | → $23 | Initiates | → Buy | Get Alert | |
| 11/16/2017 | LOXO | Buy Now | Loxo Oncology | — | — | $112 → $108 | Maintains | Buy | Get Alert | |
| 11/10/2017 | MGNX | Buy Now | Macrogenics | $1.40 | 1471.43% | $18 → $22 | Maintains | Neutral | Get Alert | |
| 10/20/2017 | LOXO | Buy Now | Loxo Oncology | — | — | $86 → $112 | Maintains | Buy | Get Alert | |
| 10/13/2017 | ARDX | Buy Now | Ardelyx | $6.29 | 201.83% | $14 → $19 | Maintains | Buy | Get Alert | |
| 10/05/2017 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 2548.56% | $114 → $156 | Maintains | Buy | Get Alert | |
| 08/23/2017 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $87 → $78 | Maintains | Buy | Get Alert | |
| 06/05/2017 | LOXO | Buy Now | Loxo Oncology | — | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 05/23/2017 | ZYME | Buy Now | Zymeworks | $25.77 | -30.15% | → $18 | Initiates | → Buy | Get Alert | |
| 03/21/2017 | MRUS | Buy Now | Merus | $96.74 | -67.96% | $26 → $31 | Downgrade | Buy → Neutral | Get Alert | |
| 01/11/2017 | KERX | Buy Now | Keryx Biopharmaceuticals | — | — | — | Upgrade | Sell → Neutral | Get Alert | |
| 12/22/2016 | MRUS | Buy Now | Merus | $96.74 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 11/15/2016 | CRSP | Buy Now | CRISPR Therapeutics | $57.25 | -66.81% | → $19 | Initiates | → Neutral | Get Alert | |
| 11/14/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | 77.73% | $66 → $64 | Downgrade | Neutral → Sell | Get Alert | |
| 11/07/2016 | MRUS | Buy Now | Merus | $96.74 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 09/12/2016 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 1860.78% | $21 → $25 | Maintains | Buy | Get Alert | |
| 08/22/2016 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | -55.51% | $10 → $8 | Maintains | Sell | Get Alert | |
| 08/19/2016 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | -55.51% | $10 → $8 | Maintains | Sell | Get Alert | |
| 08/10/2016 | ARDX | Buy Now | Ardelyx | $6.29 | 106.51% | $14 → $13 | Maintains | Buy | Get Alert | |
| 08/05/2016 | MGNX | Buy Now | Macrogenics | $1.40 | 2185.71% | $27 → $32 | Maintains | Neutral | Get Alert | |
| 08/04/2016 | MGNX | Buy Now | Macrogenics | $1.40 | 2185.71% | $27 → $32 | Downgrade | Buy → Neutral | Get Alert | |
| 08/02/2016 | LXRX | Buy Now | Lexicon Pharmaceuticals | $1.27 | 1547.06% | → $21 | Initiates | → Buy | Get Alert | |
| 06/13/2016 | MRUS | Buy Now | Merus | $96.74 | -85.53% | → $14 | Initiates | → Buy | Get Alert | |
| 06/06/2016 | MRTX | Buy Now | Mirati Therapeutics | — | — | $30 → $23 | Maintains | Buy | Get Alert | |
| 03/29/2016 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 1394.06% | $90 → $88 | Maintains | Buy | Get Alert | |
| 03/16/2016 | LOXO | Buy Now | Loxo Oncology | — | — | $24 → $25 | Maintains | Buy | Get Alert | |
| 03/03/2016 | ARDX | Buy Now | Ardelyx | $6.29 | 138.28% | → $15 | Initiates | → Buy | Get Alert | |
| 01/15/2016 | LOXO | Buy Now | Loxo Oncology | — | — | — | Initiates | → Buy | Get Alert | |
| 01/12/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.01 | — | — | Upgrade | Sell → Neutral | Get Alert | |
| 12/15/2015 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | -11.01% | $51 → $16 | Downgrade | Buy → Sell | Get Alert | |
| 12/14/2015 | PBYI | Buy Now | Puma Biotechnology | $5.89 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 09/17/2015 | MGNX | Buy Now | Macrogenics | $1.40 | 2114.29% | → $31 | Initiates | → Neutral | Get Alert | |
| 05/29/2015 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $45 | Initiates | → Buy | Get Alert | |
| 05/07/2015 | ARDX | Buy Now | Ardelyx | $6.29 | 122.4% | $20 → $14 | Maintains | Buy | Get Alert | |
| 03/03/2015 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 4416.13% | $263 → $266 | Maintains | Buy | Get Alert | |
| 11/10/2014 | ATRA | Buy Now | Atara Biotherapeutics | $17.98 | 105.78% | → $37 | Initiates | → Buy | Get Alert | |
| 07/23/2014 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 4857.56% | $99 → $292 | Maintains | Buy | Get Alert | |
| 07/14/2014 | ARDX | Buy Now | Ardelyx | $6.29 | 328.91% | → $27 | Initiates | → Buy | Get Alert | |
| 06/24/2014 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 1580.81% | $123 → $99 | Maintains | Buy | Get Alert | |
| 04/21/2014 | PBYI | Buy Now | Puma Biotechnology | $5.89 | 1988.29% | → $123 | Initiates | → Buy | Get Alert | |
| 03/06/2013 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | -83.3% | $6 → $7 | Maintains | Neutral | Get Alert | |
| 12/13/2012 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | -85.69% | $14 → $6 | Downgrade | Buy → Neutral | Get Alert | |
| 02/22/2012 | RIGL | Buy Now | Rigel Pharmaceuticals | $41.92 | -68.99% | → $13 | Upgrade | Neutral → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved